Slide featuring data from landmark clinical trials in type 2 diabetes and cardiovascular disease
Diabetes Endpoints W/ Empagliflozin
in EMPA-REG OUTCOME
Clinical Endpoints With Saxagliptin
in SAVOR-TIMI 53
Liraglutide and CV Events
in LEADER
Sitagliptin and CV Events
in TECOS
Alogliptin and CV Events
in EXAMINE
Pioglitazone and CV Events
in IRIS
Clinical Endpoints With Lifestyle Changes in Look AHEAD
Lixisenatide and CV Events
in ELIXA
PCSK9 Inhibitors
Data Slide Set